Treatment algorithm
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups: see disclaimer
neonates: nonbullous impetigo
oral antibiotics plus skin hygiene
Undertake antibiotic treatment in neonates in collaboration with a pediatric dermatologist or infectious disease specialist.
Patients in the first month of life presenting with nonbullous impetigo require oral antibiotics.
Erythromycin is the initial choice. Treatment course is 7 days.
Intranasal antibiotics are generally not used in neonates.
In addition to the antibiotic treatment, twice-daily washing with soap and water is good general skin care for all patients with impetigo, as it helps reduce the amount of bacteria on the skin. This washing routine may also be recommended for close patient contacts who may have acquired the bacteria. Chlorhexidine is not recommended in neonates (due to issues related to its potential toxicity with absorption).
Primary options
erythromycin base: consult specialist for guidance on neonatal doses
Secondary options
clindamycin: consult specialist for guidance on neonatal doses
parenteral vancomycin plus skin hygiene
Undertake antibiotic treatment in neonates in collaboration with a pediatric dermatologist or infectious disease specialist.
Vancomycin is recommended if MRSA is suspected (cases of spontaneous abscess or cellulitis; lesions that do not resolve with recommended antibiotic treatment) and/or determined by antibiotic susceptibility testing. Treatment course is usually 7 to 10 days.
Intranasal antibiotics are generally not used in neonates.
In addition to the antibiotic treatment, twice-daily washing with soap and water is good general skin care for all patients with impetigo, as it helps reduce the amount of bacteria on the skin. This washing routine may also be recommended for close patient contacts who may have acquired the bacteria. Chlorhexidine is not recommended in neonates (due to issues related to its potential toxicity with absorption).
Primary options
vancomycin: consult specialist for guidance on neonatal doses
neonates: bullous impetigo
parenteral antibiotics plus skin hygiene
Undertake antibiotic treatment in neonates in collaboration with a pediatric dermatologist or infectious disease specialist.
If antibiotic susceptibility testing indicates MRSA, vancomycin is recommended. Treatment course is usually 7 to 10 days.
Intranasal antibiotics are generally not used in neonates.
In addition to the antibiotic treatment, twice-daily washing with soap and water is good general skin care for all patients with impetigo, as it helps reduce the amount of bacteria on the skin. This washing routine may also be recommended for close patient contacts who may have acquired the bacteria. Chlorhexidine is not recommended in neonates (due to issues related to its potential toxicity with absorption).
Primary options
clindamycin: consult specialist for guidance on neonatal doses
OR
nafcillin: consult specialist for guidance on neonatal doses
OR
oxacillin: consult specialist for guidance on neonatal doses
parenteral vancomycin plus skin hygiene
Undertake antibiotic treatment in neonates in collaboration with a pediatric dermatologist or infectious disease specialist.
Vancomycin is recommended if MRSA is suspected (cases of spontaneous abscess or cellulitis; lesions that do not resolve with recommended antibiotic treatment) and/or determined by antibiotic susceptibility testing. Treatment course is usually 7 to 10 days.
Intranasal antibiotics are generally not used in neonates.
In addition to the antibiotic treatment, twice-daily washing with soap and water is good general skin care for all patients with impetigo, as it helps reduce the amount of bacteria on the skin. This washing routine may also be recommended for close patient contacts who may have acquired the bacteria. Chlorhexidine is not recommended in neonates (due to issues related to its potential toxicity with absorption).
Primary options
vancomycin: consult specialist for guidance on neonatal doses
adults, children, and infants: superficial or limited infection
topical antibiotics plus skin hygiene
These patients have no evidence of deeper soft tissue involvement (abscess, cellulitis) or hematogenous spread (fever, constitutional symptoms).
Topical antibiotics such as mupirocin, retapamulin, and ozenoxacin are the first-line treatment options, except where resistance is evident.[25]Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014 Jul 15;59(2):e10-52. https://academic.oup.com/cid/article/59/2/e10/2895845 http://www.ncbi.nlm.nih.gov/pubmed/24973422?tool=bestpractice.com [28]Koning S, van der Sande R, Verhagen AP, et al. Interventions for impetigo. Cochrane Database Syst Rev. 2012 Jan 18;(1):CD003261. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003261.pub3/full http://www.ncbi.nlm.nih.gov/pubmed/22258953?tool=bestpractice.com [29]Kwak YG, Choi SH, Kim T, et al. Clinical guidelines for the antibiotic treatment for community-acquired skin and soft tissue infection. Infect Chemother. 2017 Dec;49(4):301-25. https://www.icjournal.org/DOIx.php?id=10.3947/ic.2017.49.4.301 http://www.ncbi.nlm.nih.gov/pubmed/29299899?tool=bestpractice.com [31]Vogel A, Lennon D, Best E, et al. Where to from here? The treatment of impetigo in children as resistance to fusidic acid emerges. N Z Med J. 2016 Oct 14;129(1443):77-83. http://www.ncbi.nlm.nih.gov/pubmed/27736855?tool=bestpractice.com [32]Gropper S, Albareda N, Chelius K, et al; Ozenoxacin in Impetigo Trial Investigators Group. Ozenoxacin 1% cream in the treatment of impetigo: a multicenter, randomized, placebo- and retapamulin-controlled clinical trial. Future Microbiol. 2014;9(9):1013-23. http://www.ncbi.nlm.nih.gov/pubmed/25340832?tool=bestpractice.com [33]Rosen T, Albareda N, Rosenberg N, et al. Efficacy and safety of ozenoxacin cream for treatment of adult and pediatric patients with impetigo: a randomized clinical trial. JAMA Dermatol. 2018 Jul 1;154(7):806-13. http://www.ncbi.nlm.nih.gov/pubmed/29898217?tool=bestpractice.com There is no difference in effectiveness between topical antibiotics. Evidence indicates that topical medications are equally or more effective than oral antibiotics for limited disease.[28]Koning S, van der Sande R, Verhagen AP, et al. Interventions for impetigo. Cochrane Database Syst Rev. 2012 Jan 18;(1):CD003261. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003261.pub3/full http://www.ncbi.nlm.nih.gov/pubmed/22258953?tool=bestpractice.com Treatment course is usually 5 to 7 days. If retapamulin or ozenoxacin are used, total treatment area should not exceed 100 cm² total body surface area in adults, and 2% of total body surface area in children (9 months or older for retapamulin; 2 months or older for ozenoxacin).[1]Hartman-Adams H, Banvard C, Juckett G. Impetigo: diagnosis and treatment. Am Fam Physician. 2014 Aug 15;90(4):229-35. https://www.aafp.org/afp/2014/0815/p229.html http://www.ncbi.nlm.nih.gov/pubmed/25250996?tool=bestpractice.com [33]Rosen T, Albareda N, Rosenberg N, et al. Efficacy and safety of ozenoxacin cream for treatment of adult and pediatric patients with impetigo: a randomized clinical trial. JAMA Dermatol. 2018 Jul 1;154(7):806-13. http://www.ncbi.nlm.nih.gov/pubmed/29898217?tool=bestpractice.com [37]Galindo E, Hebert AA. A comparative review of current topical antibiotics for impetigo. Expert Opin Drug Saf. 2021 Jun;20(6):677-83. https://www.doi.org/10.1080/14740338.2021.1902502 http://www.ncbi.nlm.nih.gov/pubmed/33726585?tool=bestpractice.com
In addition to topical antibiotic treatment, twice-daily washing with soap and water is good general skin care for all patients with impetigo, as it helps reduce the amount of bacteria on the skin. For older children and adults, particularly those with more widespread skin involvement, chlorhexidine can be a good antibacterial cleanser to add to the routine.[36]The Primary Care Dermatology Society. Impetigo. May 2022 [internet publication]. https://www.pcds.org.uk/clinical-guidance/impetigo Chlorhexidine is not recommended in children younger than 4 years (due to issues related to its potential toxicity with absorption). This washing routine may also be recommended for close patient contacts who may have acquired the bacteria.
Primary options
mupirocin topical: (2%) apply to affected skin and nares three times daily
OR
retapamulin topical: (1%) apply to affected skin twice daily for 5 days
OR
ozenoxacin topical: (1%) apply to affected skin twice daily for 5 days
intranasal antibiotics
Treatment recommended for ALL patients in selected patient group
Intranasal antibiotic (applied to the nares at the same frequency as antibiotic skin application for 5 to 7 days of the month) is additionally used for patients who experience frequent recurrences of their impetigo.[36]The Primary Care Dermatology Society. Impetigo. May 2022 [internet publication]. https://www.pcds.org.uk/clinical-guidance/impetigo If several family members other than the patient are affected by impetigo, intranasal antibiotic alone would be prescribed for the unaffected individual(s). In either case, the intention is to decrease nasal colonization by bacteria. The nasal reservoir can serve as a source for reinfection of an individual or spread of the infection to close contacts.
Primary options
mupirocin topical: (2%) apply to affected nares three times daily for 7 days
adults, children, and infants: widespread cutaneous lesions
oral antibiotics plus skin hygiene
These patients have no evidence of deeper soft tissue involvement (abscess, cellulitis) or hematogenous spread (fever, constitutional symptoms).
Oral antibiotics including dicloxacillin, erythromycin, or a first-generation cephalosporin (e.g., cephalexin) are the recommended agents for these patients. Treatment course is usually 7 days.
Immunocompromised patients are at greater risk for developing a complicated course of infection; parenteral antibiotic treatment is a consideration for patients with widespread lesions and severe immune compromise.[28]Koning S, van der Sande R, Verhagen AP, et al. Interventions for impetigo. Cochrane Database Syst Rev. 2012 Jan 18;(1):CD003261. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003261.pub3/full http://www.ncbi.nlm.nih.gov/pubmed/22258953?tool=bestpractice.com [30]Wallin TR, Hern HG, Frazee BW. Community-associated methicillin-resistant Staphylococcus aureus. Emerg Med Clin North Am. 2008 May;26(2):431-55. http://www.ncbi.nlm.nih.gov/pubmed/18406982?tool=bestpractice.com
In addition to topical antibiotic treatment, twice-daily washing with soap and water is good general skin care for all patients with impetigo, as it helps reduce the amount of bacteria on the skin. For older children and adults, particularly those with more widespread skin involvement, chlorhexidine can be a good antibacterial cleanser to add to the routine.[36]The Primary Care Dermatology Society. Impetigo. May 2022 [internet publication]. https://www.pcds.org.uk/clinical-guidance/impetigo Chlorhexidine is not recommended in young children (due to issues related to its potential toxicity with absorption). This washing routine may also be recommended for close patient contacts who may have acquired the bacteria.
Primary options
dicloxacillin: children: 25-50 mg/kg/day orally given in divided doses every 6 hours; adults: 250 mg orally every 6 hours
OR
erythromycin base: children: 40 mg/kg/day orally given in divided doses every 6 hours; adults: 250 mg orally every 6 hours
OR
cephalexin: children: 25-50 mg/kg/day orally given in divided doses every 6 hours; adults: 250-500 mg orally every 6 hours
intranasal antibiotics
Treatment recommended for SOME patients in selected patient group
Intranasal antibiotic (applied to the nares at the same frequency as antibiotic skin application for 5 to 7 days of the month) is additionally used for patients who experience frequent recurrences of their impetigo.[36]The Primary Care Dermatology Society. Impetigo. May 2022 [internet publication]. https://www.pcds.org.uk/clinical-guidance/impetigo If several family members other than the patient are affected by impetigo, intranasal antibiotic alone would be prescribed for the unaffected individual(s). In either case, the intention is to decrease nasal colonization by bacteria. The nasal reservoir can serve as a source for reinfection of an individual or spread of the infection to close contacts.
Primary options
mupirocin topical: (2%) apply to affected nares three times daily for 7 days
oral antibiotics plus skin hygiene
These patients have no evidence of deeper soft tissue involvement (abscess, cellulitis) or hematogenous spread (fever, constitutional symptoms).
If MRSA is suspected (cases of spontaneous abscess or cellulitis; lesions that do not resolve with recommended antibiotic treatment) and/or determined by antibiotic susceptibility testing, appropriate antibiotic choices include clindamycin, trimethoprim/sulfamethoxazole, or doxycycline. Treatment course is usually 7 days.
In addition to topical antibiotic treatment, twice-daily washing with soap and water is good general skin care for all patients with impetigo, as it helps reduce the amount of bacteria on the skin. For older children and adults, particularly those with more widespread skin involvement, chlorhexidine can be a good antibacterial cleanser to add to the routine.[36]The Primary Care Dermatology Society. Impetigo. May 2022 [internet publication]. https://www.pcds.org.uk/clinical-guidance/impetigo Chlorhexidine is not recommended in young children (due to issues related to its potential toxicity with absorption). This washing routine may also be recommended for close patient contacts who may have acquired the bacteria.
Primary options
clindamycin: children: 10-30 mg/kg/day orally given in divided doses every 6-8 hours; adults: 150-450 mg orally every 6-8 hours
OR
sulfamethoxazole/trimethoprim: children: 8-10 mg/kg/day orally given in divided doses every 12 hours; adults: 160 mg orally every 12 hours
More sulfamethoxazole/trimethoprimDose refers to trimethoprim component.
Secondary options
doxycycline: children: 2.2 to 4.4 mg/kg/day orally given in divided doses every 12 hours; adults: 50-100 mg orally twice daily
More doxycyclineNot recommended for children younger than 8 years old.
intranasal antibiotics
Treatment recommended for SOME patients in selected patient group
Intranasal antibiotic (applied to the nares at the same frequency as antibiotic skin application for 5 to 7 days of the month) is additionally used for patients who experience frequent recurrences of their impetigo. If several family members other than the patient are affected by impetigo, intranasal antibiotic alone would be prescribed for the unaffected individual(s). In either case, the intention is to decrease nasal colonization by bacteria. The nasal reservoir can serve as a source for reinfection of an individual or spread of the infection to close contacts.
Primary options
mupirocin topical: (2%) apply to affected nares three times daily for 7 days
adults, children, and infants: deep soft tissue infection or hematogenous spread
parenteral antibiotics plus skin hygiene
Patients with evidence of soft tissue infection (abscess, cellulitis) or hematogenous spread (fever, constitutional symptoms) will require treatment with parenteral antibiotics.
Clindamycin, nafcillin, and oxacillin are all considered first-line options. Treatment course is usually 10 to 14 days. If the patient has positive blood cultures, reevaluate the status of blood cultures prior to discontinuation of parenteral treatment.
Collaboration with an infectious disease specialist (pediatric or adult) is a consideration when treating infants, children, immunocompromised patients, or any patient poorly responsive to initial parenteral antibiotic treatment.
In addition to the antibiotic treatment, twice-daily washing with soap and water is good general skin care for all patients with impetigo, as it helps reduce the amount of bacteria on the skin. For older children and adults, particularly those with more widespread skin involvement, chlorhexidine can be a good antibacterial cleanser to add to the routine.[36]The Primary Care Dermatology Society. Impetigo. May 2022 [internet publication]. https://www.pcds.org.uk/clinical-guidance/impetigo Chlorhexidine is not recommended in young children (due to issues related to its potential toxicity with absorption). This washing routine may also be recommended for close patient contacts who may have acquired the bacteria.
Primary options
clindamycin: children: 25-40 mg/kg/day intravenously/intramuscularly given in divided doses every 6-8 hours; adults: 150-450 mg intravenously/intramuscularly every 6-8 hours
OR
nafcillin: children: 100-200 mg/kg/day intravenously/intramuscularly given in divided doses every 4-6 hours; adults: 500-2000 mg intravenously every 4-6 hours, or 500 mg intramuscularly every 4-6 hours
OR
oxacillin: children: 100-200 mg/kg/day intravenously/intramuscularly given in divided doses every 4-6 hours; adults: 500-2000 mg intravenously/intramuscularly every 4-6 hours
intranasal antibiotics
Treatment recommended for SOME patients in selected patient group
Intranasal antibiotic (applied to the nares at the same frequency as antibiotic skin application for 5 to 7 days of the month) is additionally used for patients who experience frequent recurrences of their impetigo. If several family members other than the patient are affected by impetigo, intranasal antibiotic alone would be prescribed for the unaffected individual(s). In either case, the intention is to decrease nasal colonization by bacteria. The nasal reservoir can serve as a source for reinfection of an individual or spread of the infection to close contacts.
Primary options
mupirocin topical: (2%) apply to affected nares three times daily for 7 days
parenteral antibiotics plus skin hygiene
Patients with evidence of soft tissue infection (abscess, cellulitis) or hematogenous spread (fever, constitutional symptoms) will require treatment with parenteral antibiotics.
Vancomycin is recommended if MRSA is suspected (cases of spontaneous abscess or cellulitis; lesions that do not resolve with recommended antibiotic treatment) and/or determined by antibiotic susceptibility testing. Treatment course is usually 10 to 14 days. If the patient has positive blood cultures, re-evaluate the status of blood cultures prior to discontinuation of parenteral treatment.
Collaboration with an infectious disease specialist (pediatric or adult) is a consideration for infants, children, immunocompromised patients, or any patient poorly responsive to initial parenteral antibiotic treatment.
When alternatives to vancomycin are required, oritavancin, dalbavancin, and tedizolid can be considered in patients with complicated impetigo who require parenteral therapy.
In addition to the antibiotic treatment, twice-daily washing with soap and water is good general skin care for all patients with impetigo, as it helps reduce the amount of bacteria on the skin. For older children and adults, particularly those with more widespread skin involvement, chlorhexidine can be a good antibacterial cleanser to add to the routine.[36]The Primary Care Dermatology Society. Impetigo. May 2022 [internet publication]. https://www.pcds.org.uk/clinical-guidance/impetigo Chlorhexidine is not recommended in young children (due to issues related to its potential toxicity with absorption). This washing routine may also be recommended for close patient contacts who may have acquired the bacteria.
Primary options
vancomycin: children: 40 mg/kg/day intravenously given in divided doses every 6-8 hours for 10-14 days; adults: 500 mg intravenously every 6 hours, or 1000 mg intravenously every 12 hours for 10-14 days
Secondary options
oritavancin: adults: 1200 mg intravenously as a single dose
OR
dalbavancin: adults: 1500 mg intravenously as a single dose, or 1000 mg intravenously as a single dose followed by 500 mg 1 week later
OR
tedizolid phosphate: adults: 200 mg intravenously once daily for 6 days
intranasal antibiotics
Treatment recommended for SOME patients in selected patient group
Intranasal antibiotic (applied to the nares at the same frequency as antibiotic skin application for 5 to 7 days of the month) is additionally used for patients who experience frequent recurrences of their impetigo. If several family members other than the patient are affected by impetigo, intranasal antibiotic alone would be prescribed for the unaffected individual(s). In either case, the intention is to decrease nasal colonization by bacteria. The nasal reservoir can serve as a source for reinfection of an individual or spread of the infection to close contacts.
Primary options
mupirocin topical: (2%) apply to affected nares three times daily for 7 days
Choose a patient group to see our recommendations
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups. See disclaimer
Use of this content is subject to our disclaimer